My Quote Request
6505-00-201-2507
20 Products
PITRESSIN
VASOPRESSIN TANNATE INJECTION
NSN, MFG P/N
6505002012507
NSN
6505-00-201-2507
PITRESSIN
VASOPRESSIN TANNATE INJECTION
NSN, MFG P/N
6505002012507
NSN
6505-00-201-2507
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 UNITS VASOPRESSIN TANNATE EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: NONAQUEOUS VEHICLE INGREDIENT - PEANUT OIL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
0MNIPEN
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505002012509
NSN
6505-00-201-2509
0MNIPEN
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505002012509
NSN
6505-00-201-2509
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMPICILLIN ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO CONTAIN 250 MILLIGRAMS OF AMPICILLIN
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TO BE RECONSTITUTED TO 80 ML
Related Searches:
NDC00008-0055-01
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505002012509
NSN
6505-00-201-2509
NDC00008-0055-01
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505002012509
NSN
6505-00-201-2509
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMPICILLIN ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO CONTAIN 250 MILLIGRAMS OF AMPICILLIN
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TO BE RECONSTITUTED TO 80 ML
Related Searches:
7-237-4
ETHOSUXIMIDE CAPSULES,USP
NSN, MFG P/N
6505002012521
NSN
6505-00-201-2521
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHOSUXIMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: LIQUID
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
71-237-4
ETHOSUXIMIDE CAPSULES,USP
NSN, MFG P/N
6505002012521
NSN
6505-00-201-2521
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHOSUXIMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: LIQUID
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ZAR0NTIN
ETHOSUXIMIDE CAPSULES,USP
NSN, MFG P/N
6505002012521
NSN
6505-00-201-2521
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHOSUXIMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: LIQUID
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PERC0DANH0SPITALPACK
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505002041041
NSN
6505-00-204-1041
PERC0DANH0SPITALPACK
OXYCODONE AND ASPIRIN TABLETS,USP
NSN, MFG P/N
6505002041041
NSN
6505-00-204-1041
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 224.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 32.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT AND 0.380 MILLIGRAMS HOMATROPINE TEREPHTHALATE ACTIVE INGREDIENT AND 4.500 MILLIGRAMS OXYCODONE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.380 MILLIGRAMS OXYCODONE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: CARTON
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
~1: TEREPHTHALATE ACTIVE INGREDIENT AND 160.000 MILLIGRAMS PHENACETIN ACTIVE INGREDIENT
Related Searches:
LASANP0MADE
ANTHRALIN OINTMENT,USP
NSN, MFG P/N
6505002041047
NSN
6505-00-204-1047
MFG
STIEFEL LABORATORIES INC
Description
ADMINISTRATION: TOPICAL
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: JAR
Related Searches:
T407
TRIETHANOLAMINE,USP
NSN, MFG P/N
6505002041133
NSN
6505-00-204-1133
MFG
FISHER SCIENTIFIC WORLDWIDE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 PERCENTAGE, W/V TRIETHANOLAMINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
S667
SCARLET RED
NSN, MFG P/N
6505002041158
NSN
6505-00-204-1158
MFG
FISHER SCIENTIFIC WORLDWIDE
Description
UNIT PACKAGE QUANTITY: 25 GRAMS
UNIT PACKAGE TYPE: BOTTLE
Related Searches:
6209
WATER FOR IRRIGATIO
NSN, MFG P/N
6505002048894
NSN
6505-00-204-8894
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: STERILE,PYROGEN-FREE,1000 ML UNIT QTY,BOTTLE UNIT PKG TYPE
Related Searches:
S151
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505002048896
NSN
6505-00-204-8896
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH:85.000 MILLIGRAMS CYCLOHEXYLCARBINOL;STABILIZER:PRESERVATIVE AGENT
Related Searches:
331
SCOPOLAMINE HYDROBROMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048900
NSN
6505-00-204-8900
331
SCOPOLAMINE HYDROBROMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048900
NSN
6505-00-204-8900
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V HYDROXYPROPYL METHYLCELLULOSE ACTIVE INGREDIENT AND 0.250 PERCENTAGE, W/V SCOPOLAMINE HYDROBROMIDE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
Related Searches:
AVEEN00ILATED
COLLODIAL OATMEAL
NSN, MFG P/N
6505002048914
NSN
6505-00-204-8914
MFG
COOPER LABORATORIES INC
Description
DESIGN CONTROL REFERENCE: AVEEN00ILATED
GENERAL CHARACTERISTICS ITEM DESCRIPTION: OILATED,2 LB BOX
MANUFACTURERS CODE: 51870
REFERENCE NUMBER DIFFERENTIATING CHARACTERISTICS: AS DIFFERENTIATED BY PKG DATA
THE MANUFACTURERS DATA:
Related Searches:
MINTEZ0L
THIABENDAZOLE ORAL SUSPENSION,USP
NSN, MFG P/N
6505002048926
NSN
6505-00-204-8926
MINTEZ0L
THIABENDAZOLE ORAL SUSPENSION,USP
NSN, MFG P/N
6505002048926
NSN
6505-00-204-8926
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS THIABENDAZOLE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
023-109-08
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
023-109-08
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V CHLORAMPHENICOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 7.500 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
108
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
108
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V CHLORAMPHENICOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 7.500 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CHL0R0PTIC
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
CHL0R0PTIC
CHLORAMPHENICOL OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505002048930
NSN
6505-00-204-8930
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V CHLORAMPHENICOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 7.500 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
423-27
DEXTROSE IN LACTATED RINGER'S INJECTION
NSN, MFG P/N
6505002048932
NSN
6505-00-204-8932
423-27
DEXTROSE IN LACTATED RINGER'S INJECTION
NSN, MFG P/N
6505002048932
NSN
6505-00-204-8932
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 500.000 MILLILITERS RINGERS, LACTATED ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
DIBENZYLINE
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505002048934
NSN
6505-00-204-8934
DIBENZYLINE
PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505002048934
NSN
6505-00-204-8934
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PHENOXYBENZAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE